(Q36925048)

17 August 2017

1 reference

title

Fluorocarbon-based in vivo oxygen transport and delivery systems (English)

1 reference

17 August 2017

Fluorocarbon-Based in vivo Oxygen Transport and Delivery Systems (English)

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

20 November 2022

author name string

J. G. Riess

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1776239

20 November 2022

language of work or name

1 reference

1 January 1991

1 reference

full work available at URL

17 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1423-0410.1991.tb00952.x

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1423-0410.1991.tb00952.x/fullpdf

20 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

20 November 2022

1 reference

17 August 2017

61

1 reference

17 August 2017

4

1 reference

17 August 2017

225-239

1 reference

Liver, spleen, and vessels: preliminary clinical results of CT with perfluorooctylbromide

17 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Quantitative structure-in vivo half-life relationships of perfluorochemicals for use as oxygen transporters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Design, synthesis and evaluation of fluorocarbons and surfactants for in vivo applications. New perfluoroalkylated polyhydroxylated surfactants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Purification of pluronic F-68 for perfluorochemical emulsification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Perfluorochemical emulsions with fluorinated surfactants and anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Potential role of perfluorooctylbromide in the detection and characterization of liver lesions with CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1423-0410.1991.TB00952.X

Perfluoro Compounds as Blood Substitutes

21 January 2018

5

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Perfluorocarbon blood substitutes

20 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

High oxygen extraction combined with extensive oxygen consumption in the rat liver perfused with fluosol-DAR, a new perfluoro compound emulsion

20 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

U.S. Clinical Studies of the Treatment of Anemia with Fluosol-DA 20%

20 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Whole body oxygenation using intraperitoneal perfusion of fluorocarbons

20 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Perfluorooctylbromide: a new contrast agent for CT, sonography, and MR imaging

20 November 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes: analysis of structure/property relationships

20 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure

20 November 2022

25

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Erythrocyte Substitute for Perfusion of Brain

20 November 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Fluorocarbon-Polyol Artificial Blood Substitutes

20 November 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Reversal of the endocrine toxicity of commercially produced perfluorochemical emulsion.

20 November 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

[Fluorocarbons as a substitute for hemoglobin for the transport of respiratory gases]

20 November 2022

39

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Fluosol-DA as a red-cell substitute in acute anemia

20 November 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

O2 and CO2 solubility of the fluorocarbon emulsion fluosol-DA 20% and O2 and CO2 dissociation curves of blood-fluosol-DA 20% mixtures

20 November 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Metabolic and functional effects of perfluorocarbon distal perfusion during coronary angioplasty

20 November 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Reduction of myocardial ischemia during percutaneous transluminal coronary angioplasty with oxygenated Fluosol

20 November 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Does intracoronary infusion of Fluosol-DA 20% prevent left ventricular diastolic dysfunction during coronary balloon angioplasty?

20 November 2022

51

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Efficacy and Toxicity Studies with Radiopaque Perfluorocarbon

20 November 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Comparative chromatography of fresh, freeze-dried and chemically modified human haemoglobin on the cation exchanger Mono S

20 November 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

New and unexpected reactivity of saturated fluorocarbons

20 November 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Chemistry of fluorocarbons in biomedical use

20 November 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Artificial blood emulsifiers

20 November 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Reduction in the toxicity of a component of an artificial blood substitute by supercritical fluid fractionation

20 November 2022

74

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Limitation of complement activation by perfluorocarbon emulsions: superiority of lecithin-emulsified preparations

20 November 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Physical degradation of emulsions via the molecular diffusion route and the possible prevention thereof

20 November 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Fluorocarbon-based oxygen carriers: new orientations

20 November 2022

81

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Synthesis of perfluoroalkylated xylitol ethers and esters: new surfactants for biomedical uses.

20 November 2022

85

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes

20 November 2022

91

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

A perfluorochemical emulsion as an oxygen carrier

20 November 2022

97

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Prolonged retention in the circulation of emulsified lipid-coated perfluorochemicals

20 November 2022

100

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Effects of intravenous emulsified perfluorochemicals on hepatic cytochrome P-450

20 November 2022

103

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Physical properties of a new synthetic oxygen carrier

20 November 2022

104

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation

20 November 2022

105

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Influence of scheduling, dose, and volume of administration of a perfluorochemical emulsion on tumor response to radiation therapy.

20 November 2022

106

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Biocompatibility studies with a novel perfluorochemical emulsion

20 November 2022

111

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Sonographic enhancement of Doppler signals and perfused tissues with perfluorooctylbromide

20 November 2022

123

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Detection of Tumors with 19F Magnetic Resonance Imaging

20 November 2022

124

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Influence of the 100% w/v Perfluorooctyl Bromide (PFOB) Emulsion Dose on Tumour Radiosensitivity

20 November 2022

125

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

Oxygen delivery and performance in the isolated, perfused rat heart: comparison of perfusion with aqueous and perfluorocarbon-containing media.

20 November 2022

126

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

A phase I/II study of the use of Fluosol as an adjuvant to radiation therapy in the treatment of primary high-grade brain tumors.

20 November 2022

131

1 reference

https://api.crossref.org/works/10.1111/J.1423-0410.1991.TB00952.X

20 November 2022

Identifiers

1 reference

17 August 2017

1 reference